Basic Science

Michael Berens Ph.D.
Translational Genomics Research Institute

Genomics, invasion, preclinical models, profile-guided therapeutics

Oliver Bogler Ph.D.
M. D. Anderson Cancer Center

Signal transduction, cell death, proteomics, cytotoxic agents, animal models

Shi-Yuan Cheng Ph.D.
University of Pittsburgh Hillman Cancer Institute

Invasion, angiogenesis, signaling transduction.

Charles Cobbs M.D.
University of California San Francisco

Clinical:surgical, lab: tumor stem cells, RTK oncogenesis, signaling, viral oncogenesis

Waldemar Debinski M.D., Ph.D.
Wake Forest University

Molecular targeting, experimental therapeutics, tumor progression/maintenance, pre-clinical models

Juan Fueyo M.D.
University of Texas MD Anderson Cancer Center

Gene therapy, cancer stem cells, cell cycle, autophagy

Frank Furnari Ph.D.
Ludwig Institute

Glioma, signal transduction, EGFR, PTEN

Saikh Haque Ph.D.
Cleveland Clinic Foundation Lerner Research Institute

Cell survival/apoptosis, Cytokine- and growth factor signaling mechanisms, brain tumor stem cells, and angiogenesis

Isa Hussaini Ph.D.
University of Virginia

Cellular and molecular biology of astrocytoma (Invasion,Cell Proliferation,Apoptosis, small molecule inhibitors and animal models)

Mark Israel M.D.
Dartmouth-Hitchcock Medical Center

Genomics, oncogenesis (oncogenes /tumor suppressor gene), animal modeling, angiogenesis, preclinical therapeutics, metabolism, biomarkers, protein/protein interactions

Martin Jadus Ph.D.
Veterans Affairs Medical Center
Immunotherapy, angiogenesis, macrophage biology, M-CSF

C. David James Ph.D.

University of California, San Francisco

Animal model therapeutic investigations, genomics, molecular and tumor biology of receptor tyrosine kinases

Robert Jenkins M.D., Ph.D.
Mayo Clinic

Genetics, biomarkers, oligodendrogliomas

Carol Kruse Ph.D.
Burnham Institute for Medical Research

Primary malignant brain tumors, gliomas, astrocytomas, immunotherapy, cellular therapy, gene therapy, suicide or cytokine gene therapy

Catherine Nutt Ph.D.
Massachusetts General Hospital

Expression profiling, molecular genetics

Hideho Okada M.D., Ph.D.
University of Pittsburgh Cancer Institute

Immunology, immunotherapy, T lymphocyte, dendritic cell, cancer vaccines

Russell Pieper Ph.D.

University of California San Francisco
Cell Signalling, drug resistance, cell cycle control

Sandra Rempel Ph.D.

Henry Ford Hospital

Invasion, ECM-tumor interactions, gliomas, meningiomas

Gregory Riggins M.D., Ph.D.
Johns Hopkins University

Genomics, drug screens, stem cellls, kinases

Charles Stiles Ph.D.
Neural stem cells, glioma stem cells, transcription factors, signal transduction

Erwin Van Meir Ph.D.

Emory University Winship Cancer Center
Angiogenesis, hypoxia, HIF, drug discovery, oncolytic viruses, p53, pathway, tumor suppressor

Robert Wechsler-Reya Ph.D.

Duke University Medical Center
Medulloblastoma, mouse models, hedgehog, cerebellum

Please do not contact the reviewers directly. Use the Grant Review Application.

To volunteer as a grant reviewer, please e-mail chas@soc-neuro-onc.org.

Support SNO in its mission to advance neuro-oncology research and education. Give today!

Levels of Support

President's Club

Donate Now!

Platinum Members:

Benefactors:

User Name:
Password: